Vikram, Bhadrasain
National Cancer Institute (NCI),
United States
2025 Rank: 97792
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 3787 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97792 | 102638 |
| Total Cites | 5671 | 6606 |
| H-index | 39 | 42 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 29 | 29 |
| Total Cites to Single Authored Papers | 220 | 228 |
| Number of Single+First Authored Papers | 68 | 68 |
| Total Cites to Single+First Authored Papers | 1233 | 1281 |
| Number of Single+First+Last Authored Papers | 122 | 122 |
| Total Cites to Single+First+Last Authored Papers | 2632 | 2868 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5160 | 5829 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.13 |
| Self-Citation Percentage |
14.15%
|
|
Vikram, Bhadrasain
National Institutes of Health (NIH),
United States
2024 Rank: 92677
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 3647 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92677 | 96552 |
| Total Cites | 5284 | 6150 |
| H-index | 38 | 42 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 29 | 29 |
| Total Cites to Single Authored Papers | 218 | 226 |
| Number of Single+First Authored Papers | 68 | 68 |
| Total Cites to Single+First Authored Papers | 1213 | 1261 |
| Number of Single+First+Last Authored Papers | 122 | 122 |
| Total Cites to Single+First+Last Authored Papers | 2556 | 2784 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4792 | 5407 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.14 |
| Self-Citation Percentage |
14.08%
|
|
Vikram, Bhadrasain
National Cancer Institute (NCI),
United States
2023 Rank: 91235
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 3641 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91235 | 95249 |
| Total Cites | 4905 | 5721 |
| H-index | 36 | 41 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 29 | 29 |
| Total Cites to Single Authored Papers | 210 | 218 |
| Number of Single+First Authored Papers | 68 | 68 |
| Total Cites to Single+First Authored Papers | 1192 | 1240 |
| Number of Single+First+Last Authored Papers | 122 | 122 |
| Total Cites to Single+First+Last Authored Papers | 2484 | 2705 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4439 | 5008 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.14 |
| Self-Citation Percentage |
14.26%
|
|
Vikram, Bhadrasain
National Cancer Institute (NCI),
United States
2022 Rank: 90202
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 3605 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90202 | 94719 |
| Total Cites | 4487 | 5199 |
| H-index | 35 | 39 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 188 | 196 |
| Number of Single+First Authored Papers | 67 | 67 |
| Total Cites to Single+First Authored Papers | 1120 | 1168 |
| Number of Single+First+Last Authored Papers | 121 | 121 |
| Total Cites to Single+First+Last Authored Papers | 2349 | 2556 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4069 | 4565 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.14 |
| Self-Citation Percentage |
13.69%
|
|
Vikram, Bhadrasain
National Cancer Institute (NCI),
United States
2021 Rank: 87479
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 3505 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 87479 | 92473 |
| Total Cites | 4297 | 4944 |
| H-index | 34 | 38 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 187 | 192 |
| Number of Single+First Authored Papers | 67 | 67 |
| Total Cites to Single+First Authored Papers | 1094 | 1132 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 2284 | 2474 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3898 | 4357 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.13 |
| Self-Citation Percentage |
13.09%
|
|
Vikram, Bhadrasain
National Cancer Institute,
United States
2020 Rank: 82512
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 3481 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 82512 | 90401 |
| Total Cites | 3896 | 4447 |
| H-index | 33 | 35 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 177 | 182 |
| Number of Single+First Authored Papers | 67 | 67 |
| Total Cites to Single+First Authored Papers | 1046 | 1084 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 2169 | 2347 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3526 | 3915 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.14 |
| Self-Citation Percentage |
12.39%
|
|